| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 10 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HNP6
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.627 |
| CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.701 |
| CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.537 |
| CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.724 |
| CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.545 |
| CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.593 |
| CLV_PCSK_PC1ET2_1 | 99 | 101 | PF00082 | 0.593 |
| CLV_PCSK_PC7_1 | 26 | 32 | PF00082 | 0.559 |
| CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.565 |
| CLV_Separin_Metazoa | 14 | 18 | PF03568 | 0.421 |
| DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.717 |
| DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.633 |
| DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.596 |
| DOC_WW_Pin1_4 | 113 | 118 | PF00397 | 0.777 |
| DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.650 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.630 |
| LIG_eIF4E_1 | 90 | 96 | PF01652 | 0.440 |
| LIG_FHA_1 | 114 | 120 | PF00498 | 0.604 |
| LIG_MYND_1 | 117 | 121 | PF01753 | 0.529 |
| LIG_NRBOX | 91 | 97 | PF00104 | 0.438 |
| LIG_SH2_STAT3 | 75 | 78 | PF00017 | 0.743 |
| LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.482 |
| LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.700 |
| LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.576 |
| LIG_SH3_3 | 118 | 124 | PF00018 | 0.739 |
| LIG_UBA3_1 | 91 | 99 | PF00899 | 0.657 |
| MOD_CK1_1 | 63 | 69 | PF00069 | 0.691 |
| MOD_CK1_1 | 71 | 77 | PF00069 | 0.677 |
| MOD_CK2_1 | 131 | 137 | PF00069 | 0.614 |
| MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.726 |
| MOD_GlcNHglycan | 45 | 49 | PF01048 | 0.592 |
| MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.647 |
| MOD_GSK3_1 | 104 | 111 | PF00069 | 0.711 |
| MOD_GSK3_1 | 56 | 63 | PF00069 | 0.665 |
| MOD_NEK2_1 | 56 | 61 | PF00069 | 0.511 |
| MOD_NEK2_1 | 70 | 75 | PF00069 | 0.525 |
| MOD_PIKK_1 | 104 | 110 | PF00454 | 0.510 |
| MOD_PIKK_1 | 125 | 131 | PF00454 | 0.732 |
| MOD_PKB_1 | 100 | 108 | PF00069 | 0.503 |
| MOD_Plk_1 | 131 | 137 | PF00069 | 0.675 |
| MOD_Plk_4 | 49 | 55 | PF00069 | 0.724 |
| MOD_Plk_4 | 86 | 92 | PF00069 | 0.682 |
| MOD_ProDKin_1 | 113 | 119 | PF00069 | 0.776 |
| MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.655 |
| TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.644 |
| TRG_ER_diArg_1 | 143 | 145 | PF00400 | 0.698 |
| TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.560 |
| TRG_NLS_MonoExtC_3 | 140 | 145 | PF00514 | 0.649 |
| TRG_NLS_MonoExtN_4 | 138 | 145 | PF00514 | 0.653 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7D8 | Leptomonas seymouri | 47% | 78% |
| A0A0S4JKZ0 | Bodo saltans | 35% | 100% |
| A0A1X0P8A6 | Trypanosomatidae | 34% | 100% |
| A0A3S7XA93 | Leishmania donovani | 73% | 95% |
| A0A422P2F7 | Trypanosoma rangeli | 35% | 100% |
| A4ICU9 | Leishmania infantum | 73% | 95% |
| D0A2K4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
| E9ASF5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 95% |
| Q4Q240 | Leishmania major | 74% | 100% |
| V5BV99 | Trypanosoma cruzi | 36% | 100% |